Pacer Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-28,277
| Closed | -$1.96M | – | 3515 |
|
2025
Q1 | $1.96M | Buy |
28,277
+1,387
| +5% | +$96.3K | ﹤0.01% | 959 |
|
2024
Q4 | $2.31M | Buy |
26,890
+44
| +0.2% | +$3.79K | 0.01% | 898 |
|
2024
Q3 | $3.2M | Sell |
26,846
-1,295
| -5% | -$154K | 0.01% | 772 |
|
2024
Q2 | $4.02M | Sell |
28,141
-885
| -3% | -$126K | 0.01% | 643 |
|
2024
Q1 | $3.73M | Sell |
29,026
-680
| -2% | -$87.3K | 0.01% | 664 |
|
2023
Q4 | $3.07M | Buy |
29,706
+14,702
| +98% | +$1.52M | 0.01% | 680 |
|
2023
Q3 | $1.36M | Sell |
15,004
-12,060
| -45% | -$1.1M | 0.01% | 716 |
|
2023
Q2 | $2.19M | Buy |
27,064
+1,636
| +6% | +$132K | 0.01% | 703 |
|
2023
Q1 | $2.02M | Buy |
25,428
+816
| +3% | +$64.9K | 0.01% | 718 |
|
2022
Q4 | $1.67M | Buy |
+24,612
| New | +$1.67M | 0.01% | 607 |
|
2022
Q1 | – | Sell |
-25,352
| Closed | -$1.42M | – | 2471 |
|
2021
Q4 | $1.42M | Sell |
25,352
-798
| -3% | -$44.7K | 0.01% | 1001 |
|
2021
Q3 | $1.26M | Buy |
26,150
+816
| +3% | +$39.2K | 0.02% | 785 |
|
2021
Q2 | $1.06M | Sell |
25,334
-200
| -0.8% | -$8.38K | 0.02% | 822 |
|
2021
Q1 | $861K | Sell |
25,534
-1,370
| -5% | -$46.2K | 0.02% | 838 |
|
2020
Q4 | $940K | Sell |
26,904
-6,028
| -18% | -$211K | 0.02% | 728 |
|
2020
Q3 | $1.14M | Buy |
+32,932
| New | +$1.14M | 0.02% | 646 |
|
2020
Q1 | – | Sell |
-25,200
| Closed | -$729K | – | 967 |
|
2019
Q4 | $729K | Buy |
25,200
+7,020
| +39% | +$203K | 0.03% | 653 |
|
2019
Q3 | $470K | Buy |
18,180
+5,740
| +46% | +$148K | 0.01% | 1005 |
|
2019
Q2 | $317K | Buy |
+12,440
| New | +$317K | 0.01% | 1022 |
|
2017
Q4 | – | Sell |
-2,324
| Closed | -$56K | – | 1256 |
|
2017
Q3 | $56K | Buy |
+2,324
| New | +$56K | 0.01% | 1100 |
|
2013
Q4 | $311K | Buy |
+73,500
| New | +$311K | 0.07% | 352 |
|